Ebio, Sulpicia T.
HRN: 24-38-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/21/2024
01/28/2024
IV
1500mg
Every 8 Hours
CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes